Apolipoprotein A-I Mutations and Clinical Evaluation
- 1 January 2014
- book chapter
- Published by Elsevier
- p. 9-35
Abstract
No abstract availableKeywords
This publication has 114 references indexed in Scilit:
- Amyloidogenicity and Clinical Phenotype Associated with Five Novel Mutations in Apolipoprotein A-IThe American Journal of Pathology, 2011
- Speciated Human High-Density Lipoprotein Protein Proximity ProfilesBiochemistry, 2010
- Structure and Function of HDL MimeticsArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- A Novel Apolipoprotein A-1 Variant, Arg173Pro, Associated with Cardiac and Cutaneous AmyloidosisBiochemical and Biophysical Research Communications, 1999
- Extensive Intimal Apolipoprotein A1-Derived Amyloid Deposits in a Patient with an Apolipoprotein A1 MutationBiochemical and Biophysical Research Communications, 1998
- A New Case of ApoA-I Deficiency Showing Codon 8 Nonsense Mutation of the ApoA-I Gene Without Evidence of Coronary Heart DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- ApoA-IHelsinki(Lys107→0) Associated With Reduced HDL Cholesterol and LpA-I:A-II DeficiencyArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Autosomal Dominant Hypoalphalipoproteinemia Due to a Completely Defective Apolipoprotein A-I GeneBiochemical and Biophysical Research Communications, 1993
- Variant apolipoprotein AI as a major constituent of a human hereditary amyloidBiochemical and Biophysical Research Communications, 1988
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982